MEI Pharma Inc (NASDAQ:MEIP)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MEIP

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MEIP

  • Market Cap$318.440m
  • SymbolNASDAQ:MEIP
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS55279B2025

Company Profile

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer. Geographically, all the business activities function through the region of the United States.MEI Pharma Inc is an oncology company focused on the clinical development of novel therapeutics for cancer. The Company's portfolio of drug candidates includes Pracinostat, an oral histone deacetylase inhibitor.

Latest MEIP news

Currently there for this company. Visit our news hub for other news .